Orchard Therapeutics Plc ADR (ORTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ORTX | AMGN | VRTX | REGN | BMY |
| Company | Orchard Therapeutics Plc ADR | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 16.65 | 317.63 | 462.60 | 1,040.49 | 52.83 |
| High | 16.72 | 320.67 | 468.07 | 1,042.50 | 54.22 |
| Low | 16.63 | 316.18 | 460.55 | 1,025.97 | 52.41 |
| Last | 16.70 | 318.45 | 464.41 | 1,041.89 | 53.96 |
| Change | +0.05 | -1.87 | -5.35 | -5.02 | +1.06 |
| % Change | +0.30% | -0.58% | -1.14% | -0.48% | +2.00% |
| Volume | 372,300 | 332,603 | 231,337 | 135,038 | 6,011,161 |
| 20-Day Average Volume | 130,995 | 2,042,882 | 938,759 | 624,863 | 11,865,675 |
| Previous Close | 16.65 | 320.32 | 469.76 | 1,046.91 | 52.90 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 16.47 | 327.39 | 470.64 | 1,107.20 | 50.03 |
| 20-Day Raw Stochastic | 94.20% | 20.18% | 18.12% | 17.66% | 99.85% |
| 20-Day Relative Strength | 84.63% | 43.41% | 43.57% | 35.32% | 68.70% |
| Weighted Alpha | +90.00 | +17.01 | +24.02 | +20.12 | +4.79 |
| Today's Opinion | 100% Buy | 24% Buy | 8% Buy | 24% Buy | 88% Buy |
| Previous Opinion | 100% Buy | 24% Buy | 8% Buy | 24% Buy | 88% Buy |
| Last Month's Opinion | 100% Buy | 96% Buy | 48% Buy | 100% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.58% since 01/16/24 | +1.52% since 09/25/24 | +0.11% since 09/25/24 | +0.65% since 09/25/24 | +8.33% since 09/25/24 |
| Low | 16.39 on 01/17/24 | 313.37 on 09/26/24 | 458.10 on 09/26/24 | 1,028.91 on 10/02/24 | 49.72 on 09/26/24 |
| High | 16.72 on 01/23/24 | 327.98 on 09/27/24 | 472.31 on 10/01/24 | 1,070.00 on 09/27/24 | 54.12 on 10/02/24 |
| 1-Month | |||||
| %Chg | +1.71% since 12/22/23 | -4.86% since 08/30/24 | -6.78% since 08/30/24 | -12.39% since 08/30/24 | +8.33% since 08/30/24 |
| Low | 16.38 on 01/03/24 | 312.16 on 09/25/24 | 456.07 on 09/24/24 | 1,008.41 on 09/25/24 | 47.55 on 09/09/24 |
| High | 16.72 on 01/23/24 | 339.17 on 09/23/24 | 493.00 on 09/03/24 | 1,192.54 on 09/03/24 | 54.12 on 10/02/24 |
| 3-Month | |||||
| %Chg | +4.51% since 10/23/23 | +2.20% since 07/02/24 | -2.43% since 07/02/24 | -0.65% since 07/02/24 | +33.77% since 07/02/24 |
| Low | 15.78 on 10/31/23 | 306.11 on 07/03/24 | 456.07 on 09/24/24 | 1,008.41 on 09/25/24 | 39.35 on 07/05/24 |
| High | 16.72 on 01/23/24 | 346.85 on 07/25/24 | 510.64 on 08/01/24 | 1,211.20 on 08/27/24 | 54.12 on 10/02/24 |
| 6-Month | |||||
| %Chg | +215.69% since 07/21/23 | +14.99% since 04/02/24 | +12.90% since 04/02/24 | +8.71% since 04/02/24 | +2.60% since 04/02/24 |
| Low | 4.80 on 09/11/23 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.35 on 07/05/24 |
| High | 16.72 on 01/23/24 | 346.85 on 07/25/24 | 510.64 on 08/01/24 | 1,211.20 on 08/27/24 | 54.12 on 10/02/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 380,109 | 171,830,864 | 121,222,976 | 115,354,816 | 107,233,592 |
| Shares Outstanding, K | 22,761 | 536,435 | 258,053 | 110,186 | 2,027,100 |
| Annual Sales | 22,660,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -150,660,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 6,300,000 | 8,388,000,000 | 2,645,600,000 | 3,547,100,000 | 12,201,000,000 |
| Last Quarter Net Income | -35,320,000 | 746,000,000 | -3,593,600,000 | 1,432,300,000 | 1,680,000,000 |
| 60-Month Beta | 0.55 | 0.61 | 0.40 | 0.12 | 0.46 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.15 on 11/13/23 | 4.97 on 08/06/24 | -12.83 on 08/01/24 | 11.56 on 08/01/24 | 2.07 on 07/26/24 |
| Latest Earnings Date | 03/04/24 | 10/30/24 | 11/04/24 | 10/31/24 | 10/31/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | N/A | 0.600 on 07/05/24 |
| Next Ex-Dividends Date | N/A | 08/16/24 | N/A | N/A | 10/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.32 | 0.00 | 27.36 | 37.77 |